Dr. Kevin Cassidy

Kevin Cassidy, Ph.D., Biosciences Application Scientist at BIOVIA, obtained his doctorate with a focus on computational biophysics and chemistry at the University of Pittsburgh. A member of the Berman and Durrant labs, he focused on combining the advantages of both in silico and in vitro experiments to study the RNA binding protein LARP1. He interfaced between wet and dry labs to design the most effective and efficient experiments that leveraged the strengths of both disciplines. As a pre-sales scientist at BIOVIA, he has contributed to validation studies focusing on small molecule optimization. He supports the BIOVIA Biosciences solutions that have functionality for biologics and/or small molecule design/discovery, such as Discovery Studio and Generative Therapeutics Design.